These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9414311)

  • 1. A new factor V gene polymorphism (His 1254 Arg) present in subjects of african origin mimics the R2 polymorphism (His 1299 Arg).
    Lunghi B; Castoldi E; Mingozzi F; Bernardi F
    Blood; 1998 Jan; 91(1):364-5. PubMed ID: 9414311
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical significance of Arg306 mutations of factor V gene.
    Liang R; Lee CK; Wat MS; Kwong YL; Lam CK; Liu HW
    Blood; 1998 Oct; 92(7):2599-600. PubMed ID: 9746807
    [No Abstract]   [Full Text] [Related]  

  • 3. The heterozygous 20210 G/A prothrombin genotype is associated with early venous thrombosis in inherited thrombophilias and is not increased in frequency in artery disease.
    Ferraresi P; Marchetti G; Legnani C; Cavallari E; Castoldi E; Mascoli F; Ardissino D; Palareti G; Bernardi F
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2418-22. PubMed ID: 9409210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population differences in the frequency of the factor V Leiden variant among people with clinically symptomatic protein C deficiency.
    Hallam PJ; Millar DS; Krawczak M; Kakkar VV; Cooper DN
    J Med Genet; 1995 Jul; 32(7):543-5. PubMed ID: 7562967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid detection of factor V Leiden (FVQ506) by non-radioactive single strand conformation polymorphism (SSCP).
    Arruda VR; von Zuben PM; Annichino-Bizzachi JM; Costa FF
    Sangre (Barc); 1996 Oct; 41(5):379-81. PubMed ID: 8986114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High prevalence of the FVR506Q mutation causing APC resistance in a region of southern Sweden with a high incidence of venous thrombosis.
    Zöller B; Norlund L; Leksell H; Nilsson JE; von Schenck H; Rosén U; Jepsson JO; Dahlbäck B
    Thromb Res; 1996 Sep; 83(6):475-7. PubMed ID: 8885142
    [No Abstract]   [Full Text] [Related]  

  • 7. Incidence of activated protein C resistance caused by the ARG 506 GLN mutation in factor V in 113 unrelated symptomatic protein C-deficient patients. The French Network on the behalf of INSERM.
    Gandrille S; Greengard JS; Alhenc-Gelas M; Juhan-Vague I; Abgrall JF; Jude B; Griffin JH; Aiach M
    Blood; 1995 Jul; 86(1):219-24. PubMed ID: 7795227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inherited homozygous resistance to activated protein C.
    Villa P; Aznar J; Jorquera J; Mira Y; Vayá A; Fernández MA
    Thromb Haemost; 1995 Aug; 74(2):794-5. PubMed ID: 8585025
    [No Abstract]   [Full Text] [Related]  

  • 9. Resistance to activate protein C, the Arg506 to Gln mutation in the factor V gene, and venous thrombosis. Functional tests and DNA-based assays, pros and cons.
    Dahlbäck B
    Thromb Haemost; 1995 May; 73(5):739-42. PubMed ID: 7482395
    [No Abstract]   [Full Text] [Related]  

  • 10. Association of factor V deficiency with factor V HR2.
    Faioni EM; Castaman G; Asti D; Lussana F; Rodeghiero F
    Haematologica; 2004 Feb; 89(2):195-200. PubMed ID: 15003895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The factor V HR2 haplotype: prevalence and association of the A4070G and A6755G polymorphisms.
    Pecheniuk NM; Morris CP; Walsh TP; Marsh NA
    Blood Coagul Fibrinolysis; 2001 Apr; 12(3):201-6. PubMed ID: 11414634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brief report: variability of thrombosis among homozygous siblings with resistance to activated protein C due to an Arg-->Gln mutation in the gene for factor V.
    Greengard JS; Eichinger S; Griffin JH; Bauer KA
    N Engl J Med; 1994 Dec; 331(23):1559-62. PubMed ID: 7969326
    [No Abstract]   [Full Text] [Related]  

  • 13. Factor V Kuwait: a novel mutation in the coagulation factor V gene discovered in Kuwait.
    Jadaon MM; Dashti AA; Lewis HL
    Med Princ Pract; 2006; 15(2):102-5. PubMed ID: 16484835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prevalence of factor V Arg306-->Thr (factor V Cambridge) and factor V Arg306-->Gly mutations in different human populations.
    Franco RF; Elion J; Tavella MH; Santos SE; Zago MA
    Thromb Haemost; 1999 Feb; 81(2):312-3. PubMed ID: 10064012
    [No Abstract]   [Full Text] [Related]  

  • 15. The discovery of Mary's mutation.
    Asselta R; Tenchini ML; Holme R; Brosstad F; Stormorken H
    J Thromb Haemost; 2003 Feb; 1(2):397-8. PubMed ID: 12871526
    [No Abstract]   [Full Text] [Related]  

  • 16. High frequency of factor V Leiden mutation and prothrombin 20210A variant in Romanies of Eastern Hungary.
    Balogh I; Póka R; Losonczy G; Muszbek L
    Thromb Haemost; 1999 Nov; 82(5):1555-6. PubMed ID: 10595655
    [No Abstract]   [Full Text] [Related]  

  • 17. Linkage between inherited resistance to activated protein C and factor V gene mutation in venous thrombosis.
    Zöller B; Dahlbäck B
    Lancet; 1994 Jun; 343(8912):1536-8. PubMed ID: 7911873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factor V Leiden and antiphospholipid antibodies are significant risk factors for ischemic stroke in children.
    Kenet G; Sadetzki S; Murad H; Martinowitz U; Rosenberg N; Gitel S; Rechavi G; Inbal A
    Stroke; 2000 Jun; 31(6):1283-8. PubMed ID: 10835445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel factor V C2-domain mutation (R2074H) in two families with factor V deficiency and bleeding.
    Schrijver I; Houissa-Kastally R; Jones CD; Garcia KC; Zehnder JL
    Thromb Haemost; 2002 Feb; 87(2):294-9. PubMed ID: 11858490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The factor V gene A4070G mutation and the risk of venous thrombosis.
    Alhenc-Gelas M; Nicaud V; Gandrille S; van Dreden P; Amiral J; Aubry ML; Fiessinger JN; Emmerich J; Aiach M
    Thromb Haemost; 1999 Feb; 81(2):193-7. PubMed ID: 10063990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.